Skip to main content
Clinical Trials/NCT02107456
NCT02107456
Completed
Not Applicable

The Long Term Effect of Dry Needling on Myofascial Trigger Point in the Upper Trapezius Muscle.

University of Social Welfare and Rehabilitation Science1 site in 1 country33 target enrollmentJuly 2012
ConditionsPain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
University of Social Welfare and Rehabilitation Science
Enrollment
33
Locations
1
Primary Endpoint
Pain intensity
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Myofascial trigger point is one of the most common causes of musculoskeletal disorders. Myofascial trigger point in upper trapezius has been reported as a symptom in patients with neck and upper thoracic pain. The purpose of this study was to investigate the prolonged effect of dry needling on myofascial trigger point in upper trapezius muscle.

Detailed Description

Pain intensity and Disability of arm, hand and shoulder (DASH) were collected at base line and at the end of treatment sessions, two weeks and three months follow up in both groups.

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
June 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University of Social Welfare and Rehabilitation Science
Responsible Party
Principal Investigator
Principal Investigator

Amir Massoud Arab

Dr.

University of Social Welfare and Rehabilitation Science

Eligibility Criteria

Inclusion Criteria

  • Presence of a palpable taut band in muscle.
  • Presence of a hypersensitive tender spot in the taut band.
  • Reproduction of the typical referred pain pattern of the MTP in response to compression. To detect active TrPs, TrP pressure tolerance was assessed using a mechanical pressure algometer. The investigator applied continuous pressure with the algometer with an approximate pressure of 2.5 kg/cm
  • Spontaneous presence of the typical referred pain pattern and/or patient recognition of the referred pain as familiar.
  • 5- Pain of at least 30 mm on a visual analogue scale (VAS). The selected MTP of the UT muscle was located in the middle of the more nearly horizontal fibers of the UT 40.

Exclusion Criteria

  • had a history of fibromyalgia syndrome, whiplash injury, cervical spine surgery and fracture, cervical radiculopathy, having therapy within the past month before the study
  • any systematic disease such as rheumatism and tuberculosis or cervical myelopathy, multiple sclerosis
  • local infection,
  • pregnancy
  • taking anticoagulants (e.g. warfarin)
  • long-term steroid using

Outcomes

Primary Outcomes

Pain intensity

Time Frame: One year

Pain intensity using visual analogue scale (VAS) were collected at base line and at the end of treatment.

Secondary Outcomes

  • Disability(One year)

Study Sites (1)

Loading locations...

Similar Trials